IICT partners with Mylan for combination therapy trials
Click here to read full article from source
New Delhi,, Sept. 23 -- Hyderabad-based Indian Institute of Chemical Technology (IICT) has partnered with the Indian subsidiary of global pharmaceutical company, Mylan, to test combination therapies for coronavirus disease (Covid-19).
The institute had identified first three combination therapies, for Phase 3 clinical trials, based on computational modelling of molecules and laboratory-based data. Another five combinations are also in the works and will be finalised after preliminary data for the same is received.
"Mylan is a global company with a big portfolio of antiviral drugs. Some of these drugs, in combination with antibiotics or other medicines, will be used for the first three-arm trial. All the drug combinations that we are wor...
To read the full article or to get the complete feed from this publication, please Contact Us